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The SWIySNF family of chromatin-remodeling complexes facilitates
gene expression by helping transcription factors gain access to
their targets in chromatin. SWIySNF and Rsc are distinctive mem-
bers of this family from yeast. They have similar protein compo-
nents and catalytic activities but differ in biological function. Rsc is
required for cell cycle progression through mitosis, whereas SWIy
SNF is not. Human complexes of this family have also been
identified, which have often been considered related to yeast
SWIySNF. However, all human subunits identified to date are
equally similar to components of both SWIySNF and Rsc, leaving
open the possibility that some or all of the human complexes are
rather related to Rsc. Here, we present evidence that the previously
identified human SWIySNF-B complex is indeed of the Rsc type. It
contains six components conserved in both Rsc and SWIySNF.
Importantly, it has a unique subunit, BAF180, that harbors a
distinctive set of structural motifs characteristic of three compo-
nents of Rsc. Of the two mammalian ATPases known to be related
to those in the yeast complexes, human SWIySNF-B contains only
the homolog that functions like Rsc during cell growth. Immuno-
fluorescence studies with a BAF180 antibody revealed that SWIy
SNF-B localizes at the kinetochores of chromosomes during mitosis.
Our data suggest that SWIySNF-B and Rsc represent a novel
subfamily of chromatin-remodeling complexes conserved from
yeast to human, and could participate in cell division at kineto-
chores of mitotic chromosomes.
ATP-dependent chromatin-remodeling complexes facilitatethe opening of chromatin structures to allow transcription
and other metabolic reactions to occur on DNA. All such
complexes contain an SWI2ySNF2-like ATPase and use the
energy of ATP-hydrolysis to disrupt nucleosomes (reviewed in
refs. 1–3). SWIySNF and Rsc are closely related chromatin-
remodeling complexes initially discovered in yeast (4–6). Both
types of complex engage in transcriptional regulation (7–11).
They are similar in structures, sharing two identical subunits and
at least four other homologous components (12). Also, both
complexes can disrupt nucleosome structures in the presence of
ATP, which leads to increased binding of transcription factors to
nucleosomes (4, 6, 13, 14). However, the gene cohorts regulated
by each complex seem to be distinctive. SWIySNF is not
essential for yeast viability, whereas loss of Rsc is lethal. Also,
Rsc is notably required for cell cycle progression through mitosis
(6, 15–17), whereas SWIySNF and other known ATP-dependent
chromatin-remodeling complexes are not. However, SWIySNF
is required for yeast to efficiently exit from mitosis by mediating
expression of some mitotic genes (18).
We and others have described several human ATP-dependent
chromatin-remodeling complexes (19–21). These complexes
have been implicated to participate in diverse cellular processes,
including transcriptional regulation (22, 23), integration of viral
genomes into host chromatin (24), viral DNA replication (25),
cell cycle regulation (26, 27) and tumorigenesis (28, 29). They
contain either BRG1 or hbrm, two orthologs of yeast
SWI2ySNF2-like ATPases. Each particle comprises about 10
subunits named BRG1- or hbrm-associated factors (BAFs), most
of which are homologous to components of yeast SWIySNF and
Rsc complexes (20, 30–32). However, no human subunit iden-
tified thus far is specifically similar to a subunit of only one yeast
complex but not the other. It is therefore unclear which human
complex corresponds to yeast SWIySNF or Rsc. We show here
that BAF180, a subunit of the previously detected human
SWIySNF complex B, possesses unique structural motifs con-
served in 3 Rsc subunits, suggesting that complex B is related to
Rsc. Because the old name ‘‘SWIySNF complex B’’ incorrectly
implies that it is a homolog of SWIySNF, we have renamed this
complex Polybromo, BRG1-associated factors (PBAF) (see be-
low). We also report that PBAF localizes at kinetochores of
mitotic chromosomes. This localization of PBAF is consistent
with the yeast data that Rsc is required for cell cycle progression
through mitosis and suggests that PBAF and Rsc may have a
kinetochore function during cell division.
Materials and Methods
Purification of PBAF and Cloning of BAF180. PBAF (SWIySNF
complex B) was purified with a BRG1 antibody-column from
human KB cell nuclear extract as described (20). The complex on
the antibody beads was either used directly for enzymatic assays
or eluted with 0.1 M glycine (pH 2.5) for analysis by SDSyPAGE.
The bands containing proteins of interest were sequenced by
microspray tandem mass spectrometry (MSyMS) as described
(33). The peptides from BAF180 matched several human ex-
pressed sequence tags (ESTs) and the chicken Polybromo gene.
A cDNA library from Jurkat T cells was screened with the EST
DNAs as probes to obtain BAF180 cDNA clones.
A rabbit polyclonal antibody was made against a fusion protein
containing amino acid residues of 111–206 of BAF180 fused to
the maltose-binding protein (New England Biolabs). The anti-
body was affinity purified and used for immunoblotting and
immunoaffinity purification (20). The load fraction for BAF180
antibody column is the same one used for PBAF purification
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using BRG1 antibody (Fig. 1a). The column was washed with
Buffer D [20 mM Hepes (pH 7.9)y0.5 mM EDTAy5% glycer-
oly1 mM PMSFy0.1 mM DTT] containing 0.5 M KCl, and with
Buffer D without any salt. In immunoblot analysis, 2% of the
load and flowthough fractions and 5% of the eluted complex
(peak fractions) were assayed.
Human SWIySNF complexes A and B have also been purified
from the HeLa cell line that stably expresses f lag-tagged
hSNF5yBAF47 as described (34). One difference is that our
immunopurification was performed after phosphocellulose frac-
tionation of the nuclear extract as indicated in Fig. 1.
Northern blotting was done by using a fragment of BAF180
(nucleotides 1582–2161) as a probe. The human multitissue blot
was purchased from CLONTECH.
Characterization of PBAF. Superose 6 gel-filtration chromatogra-
phy was performed by using Buffer D containing 0.3 M KCl. The
load fraction was the DEAE fraction used for PBAF purification
by BRG1 antibody column (Fig. 1a).
The mononucleosome disruption assay was done as described
(13, 33). The complexes bound to the antibody beads were
directly used in the assay. The amounts used were comparable
by silver staining analysis on gels.
Immunofluorescence. Fixation and staining of Ptk1 cells were done
as described (35). Antibodies against BAF180 and dynein inter-
mediate chain (70.1; Sigma) were used at dilutions 1:1,500 and
1:500, respectively. In some experiments, cells were pretreated
with nocodazole (10 mM) for 30 min before fixation. Optical
sections of fluorescently labeled cells were obtained by using a
multimode digital imaging system (36).
Results
BAF180 Distinguishes Two Similar Human Chromatin-Remodeling
Complexes. We have previously purified two different human
SWIySNF-related complexes, BAF (also called SWIySNF-A)
and PBAF (SWIySNF-B)(20) (Fig. 1 a and b). These complexes
can be distinguished, because BAF contains BAF250, whereas
PBAF harbors BAF180, -200, and -240. Cloning of BAF250
revealed that it has a structural motif conserved in yeast SWI1
but not any Rsc components (51), suggesting that BAF is more
related to SWIySNF. We purified BAF180 of PBAF and sub-
jected it to mass spectrometry microsequencing. Nine peptides
were obtained that match the chicken Polybromo gene and
several human EST sequences. Several overlapping human
cDNA clones were isolated by using the EST sequences as
probes. Sequence analysis of these cDNAs revealed an ORF of
1582 amino acids containing all of the detected peptide se-
quences. An antibody to a region of the predicted ORF recog-
nized the 180-kDa band of PBAF on immunoblots (Fig. 1c),
indicating that the cDNA indeed encodes BAF180.
BAF180 Is a Specific Subunit of PBAF Complex. The SWIySNF
complex B (PBAF) obtained from our purification is slightly
different from the one described by Kingston and colleagues (19,
37), despite the fact that the purification schemes are similar.
Their complex B does not appear to contain any polypeptides
near the size of BAF180. The different results between the two
labs motivated us to test the possibility whether BAF180 is a
contaminant in our procedure. We used the same cell line
described by Kingston’s group in our purification. This cell line
stably expresses flag-tagged hSNF5yBAF47, permitting isola-
tion of human SWIySNF-related complexes by use of a mono-
clonal antibody against the flag-epitope (34). The complexes
purified by using this antibody resembled those obtained by using
BRG1 antibody, with complex B containing polypeptides with
gel mobility similar to BAF180 (Fig. 1d). Immunoblot analysis
confirmed the identity of these polypeptides as BAF180 (Fig.
1e). As a control, mock purification by using extracts from cells
that lack tagged-hSNF5 failed to yield BAF180 or any other
BAFs, indicating that the association between BAF180 and
complex B is specific. In addition, complex B purified with a
polyclonal antibody against hSNF5 also contains BAF180 (data
not shown). These data indicate that BAF180 is not a contam-
inant, but an intrinsic subunit of PBAF.
We note that another polypeptide, previously referred to as
BAF110 in complexes purified with polyclonal antibodies against
BRG1 and hSNF5 (20), is absent in complexes isolated with the
flag antibody (Fig. 1d). It remains to be determined whether
BAF110 is a true subunit or a contaminant.
BAF180 Is a Homolog of Chicken Polybromo and Contains Structural
Motifs Characteristic of Yeast Rsc. BAF180 is 90% identical to
chicken Polybromo (PB1), which was cloned during a search for
genes containing bromodomains, but has no known function (38)
(Fig. 2a). PB1 was found to possess 5 bromodomains, 2 bromo-
adjacent homology (BAH) regions, and one high-mobility-group
Fig. 1. BAF180 distinguishes two similar human chromatin-remodeling
complexes. (a) A diagram of the purification scheme for BAF and PBAF
complexes (20). Previously assigned names for these complexes are given in
parentheses. (b) A silver-stained SDS-gel showing BAF and PBAF purified with
BRG1 antibody. Unique components are marked with arrows. The band
designated as BAF240 (open arrow) was found to be present in substoichio-
metric amounts by both BRG1 and BAF180 antibodies (see Fig. 3a). Some IgG
and crosslinked-IgG are indicated with an asterisk. (c) Immunoblot analysis of
the load, flowthrough (FT), and eluate fractions from the BRG1 antibody
column. The doublet bands of BAF180 may represent gene products derived
from alternatively spliced mRNA. (d) A silver-stained SDS-gel of the human
SWIySNF complex A (lane 3) and B (lane 5) isolated by using a monoclonal
antibody against the flag-tagged hSNF5 (34). Immunopurification was per-
formed by using either unfractionated nuclear extract (NE), or fractions from
phophocellulose (P11) fractionation of the nuclear extract as indicated on top
of the figure (lanes 2–5). Mock purifications (lanes 2 and 4) were done by using
extracts derived from regular HeLa cells that do not express the flag-hSNF5.
BAF200 may correspond to the protein referred to as p210 in ref. 37. A
polypeptide in complex A, marked as ‘‘unknown,’’ appears to be present in the
mock purification and could be a contaminant. (e) Immunoblot analysis of the
SWIySNF complex B from Fig. 1d. Nuclear extract (lane 1) was shown as a
control.
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(HMG) motif. All these features are conserved in BAF180. We
noted that both BAF180 and PB1 also have one other bromo-
domain (hBr6) that diverges somewhat from the standard con-
sensus sequence (Fig. 2b). In addition, the BAH1 region of
BAF180 is about 20 amino acids shorter at its N terminus (Fig.
2c). The mRNA of BAF180 was detected in several human
tissues (Fig. 2d).
BLAST searches of the complete genome database of Saccha-
romyces cerevisiae detected no yeast gene with the same domain
structure as BAF180. However, the same searches revealed that
the top three homologs of BAF180 are genes encoding Rsc
subunits: Rsc1, Rsc2, and Rsc4 (Fig. 2a). In addition, Rsc1 and
Rsc2 are the only yeast genes that possess both a bromodomain
and a BAH region, indicating that they are the closest relatives
of BAF180 in this species. Because the number of bromodomains
(6) and BAH regions (2) in BAF180 is identical to the total of
all three Rsc proteins (Fig. 2 b and c), we propose that BAF180
is a homolog of all three Rsc subunits combined (yeast Rsc
proteins lack the HMG-domain present in BAF180, but Rsc1 and
Rsc2 contain AT-hook motifs that can similarly bind the minor-
groove of DNA with low sequence-specificity). Notably, the
BAH regions and minor-groove binding domains present in
PBAF and Rsc are missing in yeast SWIySNF. The data and
analyses thus suggest that PBAF is structurally more related to
Rsc than to SWIySNF. The fact that Rsc1yRsc2yRsc4 and
BAF180 share many conserved structure motifs further suggests
that these proteins are important for functions of their corre-
sponding complexes. Indeed, single mutants of rsc1 or rsc2 are
nonessential for yeast growth, whereas the double mutant is
lethal (39).
The BAF180 Equivalent of Drosophila melanogaster and Caenorhab-
ditis elegans Is the Closest Relative of Rsc1 and Rsc2 in Their Entire
Genomes. It remains to be determined whether BAF180 is the
closest human relative of Rsc1, Rsc2, and Rsc4. Because the
human genome is not completely assembled, we cannot rule out
the possibility that other human genes may be more similar to the
three Rsc genes than is BAF180. However, in the completed
Drosophila and C. elegans genomes, sequence searches revealed
a single homolog of BAF180 present in each organism: CG11375
and CE05310, respectively (Fig. 2a). All structural domains
identified in BAF180 are conserved in these two homologs.
Importantly, when sequences of Rsc1, Rsc2, and Rsc4 were used
to search genomes of these two organisms, CG11375 and
CE05310 were also found as the top homologs for all three Rsc
genes (data not shown). In fact, no other fly or nematode genes
harbor both a bromodomain and a BAH region, suggesting that
CG11375 and CE05310 are the closest relatives for Rsc1 and
Rsc2. We infer that, during evolution between yeast and C.
elegans, Rsc1, Rsc2, and Rsc4 became fused to form a single
gene. Comparable fusions have been reported for many other
proteins. For example, human transcription cofactor TAF250
was shown to be a combined homolog of two yeast TAFs:
yTAF145 and BDF1 (40). Based on the observation that some
pairs of interacting proteins have homologs in another organism
fused into a single polypeptide, a computational method has
been developed to predict thousands of interacting protein pairs
from genome sequences (41).
PBAF and BAF Share More Identical Subunits Than Yeast SWIySNF and
Rsc. Because BAF180 is a unique subunit of PBAF, immunopu-
rification by using its antibody should isolate PBAF but not BAF.
Indeed, the complex isolated with BAF180 antibody exhibits an
electrophoretic pattern on a SDS-gel strikingly similar to that of
PBAF purified with BRG1 antibody, and different from BAF
(compare Fig. 3a with Fig. 1b). Overall, up to eight PBAF
subunits were found to be identical to those in BAF by immu-
noblotting (Fig. 3b and Table 1). The number of identical
subunits in human complexes is significantly more than that in
yeast SWIySNF and Rsc, which share only two identical subunits
and have more orthologous subunits (at least four). To make
certain of this finding, we performed mass spectrometry micro-
sequencing of several PBAF subunits that are known to have
orthologs. BAF60 is known to have three different human
orthologs, whereas BAF53 has two. BAF complex contains only
BAF60a and BAF53a (ref. 30; data not shown). Mass spectro-
metric analysis confirmed the immunoblot data that hRsc con-
tains only BAF60a, but not BAF60b or BAF60c; it harbors
BAF53a but not BAF53b (Table 1 legend). We have also
analyzed PBAF purified directly from nuclear extract by using
BAF180 antibody and obtained the same results (data not
shown). The data thus underscore one difference between
human and yeast complexes.
We noticed that BAF47yhSNF5 isolated with BAF180 anti-
body reacted poorly with its antibody on immunoblot (Fig. 3b).
However, mass spectrometric analysis of this polypeptide re-
vealed the presence of peptides derived from hSNF5 peptides
(Table 1 legend). In addition, PBAF isolated with the monoclo-
nal antibody against f lag-hSNF5 contains BAF180 (Fig. 1 d
Fig. 2. BAF180 is a human homolog of chicken Polybromo and contains
structural motifs similar to yeast Rsc1yRsc2yRsc4. (a) Schematic representa-
tion of domain structures of human BAF180, chicken Polybromo, ORFs from
Drosophila (CG11375) and C. elegans (CE05310), and yeast Rsc1yRsc2yRsc4.
The BAH1 region of BAF180 is about 20 amino acids shorter than the motifs in
other proteins. (b and c) Alignment of bromodomains (Br) and BAH regions for
hBAF180, chicken PB1 (gBAH), and the three yeast Rsc subunits. A consensus
sequence is shown at the bottom. The BAH regions of Ash1 (a Drosophila
trithorax group protein) and mta1 (a subunit of nucleosome remodeling and
histone deacetylation chromatin-remodeling complex; ref. 33) are shown for
comparison. (d) Northern blotting of total RNA from multiple human tissues
by using BAF180 or actin DNA as probes.








and e). Furthermore, PBAF purified with a polyclonal antibody
against hSNF5 similarly includes BAF180 (data not shown). All
these data indicate that hSNF5 is a component of PBAF. It is
possible that hSNF5 in PBAF is posttranslationally modified,
which reduced the interaction between the antibody and antigen
on immunoblot.
PBAF Contains Only BRG1 but Not hbrm. Immunoblot analysis of
PBAF purified on a BAF180 antibody column revealed two
important differences between PBAF and BAF. First, PBAF
contains BAF180 but not BAF250 (Fig. 3c), consistent with the
silver-staining analysis of the two complexes on SDS gels (see
Fig. 3a). Second, PBAF contains only BRG1 but not hbrm, a
result further confirmed by microsequencing (Table 1 legend).
The finding that PBAF contains only BRG1 is in contrast to the
BAF complex that can contain either of the two ATPases (51).
It should be noted that our previous purification by using an
hbrm antibody has obtained BAF180 and PBAF, suggesting that
hbrm could associate with BAF180 or PBAF (20). However, that
antibody was raised against a region moderately conserved
between BRG1 and hbrm (about 60% identity). In light of our
current observations, we suspect that the hbrm antibody may
have immunoisolated the PBAF complex through antibody
crossreactivity with BRG1.
The molecular weight of PBAF was estimated by using Su-
perose 6 gel-filtration chromatography. It fractionates as a
complex of about 1.5–2 MDa (Fig. 3d), similar to the size of
human BAF or yeast SWIySNF (23, 42). It is somewhat larger
than yeast Rsc, which was estimated as a complex of 1 MDa (6).
PBAF Contains an ATP-Dependent Nucleosome Disruption Activity
Similar to BAF. PBAF purified with BAF180 antibody was tested
for its ATP-dependent nucleosome disruption activity by using
the same assay previously used for yeast SWIySNF, human BAF,
and nucleosome remodeling and histone deacetylation chroma-
tin-remodeling complexes (13, 31, 33). In this assay, a 176-bp
fragment of 5S ribosomal DNA containing a nucleosome-
positioning sequence was assembled into a rotationally phased
mononucleosome. DNase I digestion of this nucleosome gener-
ates a characteristic 10-bp ladder on denaturing PAGE (Fig. 4,
compare lanes 2 with 1). PBAF purified with either BAF180
antibody (lanes 6 and 7) or BRG1 antibody (lanes 8 and 9)
strongly disrupts the 10-bp ladder in the presence but not in the
absence of ATP. The disrupted pattern is similar to that gen-
erated by the BAF complex (lanes 4 and 5). Thus, PBAF and
BAF complexes, although distinguishable, share structural as
well as catalytic features.
PBAF Is Localized to Kinetochores of Mitotic Chromosomes in the
Absence of Microtubules. Rsc is required for cell cycle progression
through mitosis in yeast. The mitotic function of Rsc prompted
us to investigate whether PBAF may play a similar role in cell
division. We analyzed the intracellular localization of PBAF
during several phases of cell cycle by indirect immunofluores-
cence using a BAF180 antibody. Cytoplasmic dynein, which is
known to be present at kinetochores and mitotic spindles during
cell division (43, 44), was costained and served as a marker. In
interphase cells, BAF180 antibody strongly stains nuclei, con-
sistent with the biochemical data for PBAF as a nuclear complex
(Fig. 5 Top). In prometaphase cells (Fig. 5 Middle), PBAF has
overlapping colocalization with dynein at some kinetochores and
at spindle poles. The kinetochore localization of PBAF was also
evident in cells arrested at prometaphase by treatment of a
microtubule-destabilizing drug, nocodazole (Fig. 5 Bottom). Our
data are consistent with a role for PBAF at kinetochores during
mitosis. The localization of PBAF at kinetochores was observed
only in prometaphase, but not in metaphase, anaphase, telo-
phase, or cytokinesis (data not shown). The association of PBAF
with spindle poles has been seen throughout prometaphase and
metaphase and under several conditions of cell fixation (data not
shown).
Discussion
The SWIySNF family of chromatin-remodeling complexes in-
cludes SWIySNF and Rsc from yeast, BAF (SWIySNF-A) and
PBAF (SWIySNF-B) from human. They share at least six
homologous subunits (Table 1), and therefore very likely overlap
substantially in structure. Most previous studies, however, have
inferred a close relation between the human complexes and yeast
SWIySNF. In fact, all these human complexes have been re-
ferred to as ‘‘SWIySNF-related’’ or simply ‘‘human SWIySNF.’’
The importance of our finding is that it demonstrates that PBAF
is structurally related to Rsc rather than SWIySNF. This finding
may prompt reconsideration of the interpretation of experi-
ments that used a mixture of BAF and PBAF. Some biological
functions previously assigned to ‘‘human SWIySNF’’ may actu-
ally be attributable to the ‘‘human Rsc’’ (PBAF) complex.
BAF180 is likely a combined homolog of yeast Rsc1, Rsc2, and
Rsc4. It confers a set of biochemical features to PBAF similar to
Fig. 3. The PBAF complex contains both common and distinctive subunits
compared with BAF. (a) A silver-stained SDS-gel showing PBAF purified with
BAF180 antibody (lane 2). BAF complex was shown as a control (lane 1).
Unique components are marked with arrows. The presence of IgG is indicated
by an asterisk. Several polypeptides that have been further identified by mass
spectrometry analysis were denoted with #. (b and c) Immunoblot analysis of
the load, flowthrough (FT), and eluate fractions from a BAF180 antibody
column. The doublet bands of BAF180 may represent isoforms from alterna-
tively spliced mRNA. (d) Immunoblot analysis of elution profile of a Superose
6 gel-filtration chromatography to estimate the molecular mass of PBAF.
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those provided for yeast Rsc by the three Rsc proteins. The same
three yeast proteins are the only unique subunits of Rsc that have
a homolog in the completed C. elegans database (B. Cairns,
personal communication). The fact that no other Rsc proteins
are conserved in higher eucaryotes is consistent with the notion
that the only conserved biochemical markers for this subfamily
of complexes are those present in BAF180 and in Rsc1, Rsc2, and
Rsc4. Our study thus suggests that Rsc and PBAF represent an
evolutionarily conserved subfamily of chromatin-remodeling
complexes. SWIySNF and BAF would represent the other
subfamily, with its own distinctive structural motifs (51).
If human PBAF and BAF have functions as distinct as their
yeast counterparts, the subunits unique to each complex must
confer specificity. Indeed, the domains present in BAF180 are
all capable of targeting PBAF to chromatin. The bromodo-
mains and BAH-regions are conserved in yeast Rsc1yRsc2 and
are required for the Rsc functions (39). Structural analysis has
suggested that a bromodomain can serve as an acetyl-lysine-
binding motif, and may target proteins to acetylated chromatin
(45). The function of BAH is currently unknown, but HMG
domains can bind DNA or chromatin and play ‘‘architectural’’
roles during formation of higher-order nucleoprotein
complexes (46). It is therefore possible that, through these
domains, BAF180 anchors PBAF to its specific sites in
chromatin.
Distinguishing the two distinct subfamilies of complexes may
help to rationalize previously puzzling genetic data. Both
Fig. 4. Human PBAF contains an ATP-dependent mononucleosome disrup-
tion activity similar to BAF. An autoradiograph from mononucleosome dis-
ruption assay with PBAF purified with either BAF180 (B180) or BRG1 antibod-
ies. The result for BAF is shown for comparison. The complexes and templates
used are shown above figure. C, A control using antibody beads without
complex loaded. The presence (1) or absence (2) of 1 mM ATP is indicated.
Fig. 5. PBAF localizes at mitotic kinetochores and spindle poles. Immuno-
fluorescence micrographs of cells in interphase (Top), prometaphase without
nocodazole (Middle), and prometaphase in 10 mM nocodazole (Bottom). The
small inserts in the lower right-hand corners of the bottom row illustrate
colocalization of PBAF and dynein at an enlarged kinetochore. The kineto-
chore that appears in the zoomed Inset is marked by a box in the image
obtained from differential interference contrast light microscopy (DIC). DNA
was visualized by 49,6-diamidino-2-phenylindole (DAPI) staining. In the over-
lay column, green represents PBAF staining and red represents dynein. The
arrows indicate the spindle poles. Scale bar 5 5 mm.
Table 1. Human BAF and PBAF components and their yeast orthologs
BAFs
Human Yeast orthologs
Known domainsBAF PBAF SWIySNF Rsc
BAF250yp270 1 2 SWI1 — ARID
BAF180 2 1 — Rsc1, 2, 4 Bromo, BAH, HMG
BRG1 1 1 SWI2 STH1 ATPase, bromo
hbrm 1 2 SWI2 — ATPase, bromo
BAF170 1 1 SWI3 Rsc8 Myb, Leu-zipper
BAF155 1 1 SWI3 Rsc8 Myb, Leu-zipper
BAF60a 1 1 SWP73 Rsc6
BAF57 1 1 — — HMG, coiled-coil
BAF53 1 1 ARP7, 9 ARP7, 9 Actin-related protein
Actin 1 1 — — ATPase, Ca11 binding
BAF47 1 1 SNF5 SFH1
Microsequencing was done for selected PBAF subunits. Twelve peptide sequences were obtained for the
190-kDa band: 10 are specifically from BRG1; 2 from sequences conserved between BRG1 and hbrm; and none is
hbrm-specific. All 3 peptide sequences obtained for the 60-kDa band are from BAF60a, but not BAF60b or BAF60c.
All 6 peptides for the 53-kDa band are from BAF53a. From the 48-kDa band, 3 peptides are from actin and 5 are
from hSNF5yBAF47. BAF250 has been identified as the same protein as p270 (51), which has been independently
cloned by Moran and colleagues (48, 49). They found that p270 is related to yeast SWI1 and Drosophila Osa and
showed that p270 associates with several BAF subunits. Osa has been shown to be a subunit of a Drosophila
SWIySNF-related complex (50).








SWI2ySNF2-related ATPases in mammals, brm and BRG1,
have been genetically altered in mice and tissue culture cells.
Mice in which the mbrm gene was disrupted were viable (26),
whereas F9 teratocarcinoma cells deleted for the mBRG1 gene
were inviable (47). These results parallel those in yeast, where
cells inactivated of SWI2ySNF2 (the ATPase of SWIySNF) are
viable, whereas disruption of STH1 (the ATPase of Rsc) is
lethal. The data imply that brm and BRG1 might be the
functional equivalents of SWI2ySNF2 and STH1, respectively,
in mammalian cells. In accord with these genetic data, we found
that both hbrm and BRG1 are present in BAF (51), but only
BRG1 is present in PBAF (Fig. 3c). Consequently, disrupting the
brm gene would abolish only the subset of BAF complexes that
have brm, but not those containing BRG1; and all PBAF
complexes would remain intact. In contrast, deletion of the
BRG1 gene similarly abolished only a subset of BAF. But
importantly, it completely eliminated the PBAF complexes,
leading to cell death. The data further suggest that mammalian
PBAF, like its yeast counterpart Rsc, may be essential for cell
growth.
Our observation that PBAF localizes to kinetochores of
mitotic chromosomes implies that PBAF may play a role there
during mitosis. This notion is consistent with several yeast studies
for the related Rsc complex. First, several rsc mutants are
blocked at G2yM transition of the cell cycle (15–17). This block
depends on the spindle-assembly checkpoint (17), but not the
DNA-damage checkpoint (16). Because the spindle checkpoint
is usually activated by a failure of chromosome attachment to
microtubules or by spindle damage, Rsc is probably required for
either kinetochore function, or spindle assembly, or both. Sec-
ond, an rsc mutant is more sensitive to a microtubule-
destabilizing drug (17). The increased sensitivity of cells to
microtubule-destabilizing drugs is a phenotype commonly ob-
served in mutants of kinetochore components, or mutants of
tubulin, microtubule-associated proteins, and components of the
spindle checkpoint. Third, an rsc mutant exhibits increased
frequency of non-disjunction of minichromosomes, which could
be caused by defective interactions between kinetochores of
paired sister chromatids and spindles (17). Fourth, an rsc mutant
displays altered chromatin structure at centromeres (17). Two
earlier models have been proposed to explain these data. One
model proposed that the altered centromeric chromatin struc-
ture in the rsc mutant may impair kinetochore functions and lead
to execution of the spindle checkpoint (17). The second model
hypothesized that Rsc may be needed for transcription of genes
required for mitosis (16, 17). Our observation appears to favor
the first model. It remains to be investigated, however, whether
PBAF has additional kinetochore functions other than main-
taining centromeric chromatin structure.
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